NVRO's HFX iQ SCS system receives CE Mark Certification in Europe. Nevro expects to begin launching HFX iQ in select European countries from the first quarter of 2025.

Nevro Corp ( (NVRO) ) just unveiled an announcement. Nevro Corp. reported a better-than-expected worldwide revenue and adjusted EBITDA for Q3 ...

Philadelphia-based Rothman Orthopaedic Institute has been at the forefront of spine care, and recently a team partnered with Thomas Jefferson University Hospita ...

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

KNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...

The company is facing significant headwinds in its U.S. core Spinal Cord Stimulation (SCS) market, where sales have continued to decline and trials have decelerated, raising concerns about the company ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised ...

Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE ...